| Product Information |
BR-1420_PI_01.pdf
|
| Registration Number |
BR-1420
|
| Generic Name |
Insulin Degludec + Liraglutide
|
| Brand Name |
Xultophy
|
| Dosage Strength |
100 U/3.6mg per mL
|
| Dosage Form |
Solution For Injection (SC)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Antidiabetics
|
| Packaging |
3 mL Type I glass cartridge with bromobutyl and
isoprene laminate rubber and red bromobutyl rubber plunger assembled in a pen injector (Box of 5's)
|
| Manufacturer |
Novo Nordisk Pharmaceutical Industries, LP
|
| Country of Origin |
United States of America
|
| Trader |
Novo Nordisk A/S
|
| Importer |
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
| Distributor |
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
| Application Type |
Initial
|
| Issuance Date |
20 September 2022
|
| Expiry Date |
20 September 2027
|